SCN1A and Dravet syndrome: Various approaches have been used to describe and characterize the condition, most notably heterologous expression of Nav1.1 mutants [6,7] and, more recently, the development of DS mouse models, which are based on heterozygotes of an Scn1a knock-out/knock-in [8,9], or cell-type specific conditional knock-out [10,11].